Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.

Frontiers in immunology·2024
Same author

Chronic Hippocampal Expression of Notch Intracellular Domain Induces Vascular Thickening, Reduces Glucose Availability, and Exacerbates Spatial Memory Deficits in a Rat Model of Early Alzheimer.

Molecular neurobiology·2018
Same author

Deciphering variability in the role of interleukin-1β in Parkinson's disease.

Reviews in the neurosciences·2016
Same author

Glial Cell-Elicited Activation of Brain Microvasculature in Response to Brucella abortus Infection Requires ASC Inflammasome-Dependent IL-1β Production.

Journal of immunology (Baltimore, Md. : 1950)·2016
Same author

Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z.

The American journal of pathology·2012
Same author

CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.

Brain, behavior, and immunity·2012

Related Experiment Videos

Parkinson's disease and systemic inflammation.

Carina C Ferrari1, Rodolfo Tarelli

  • 1Laboratorio de Terapias Regenerativas y Protectoras del Sistema Nervioso, Fundación Instituto Leloir, Patricias Argentinas 435, C1405BWE Buenos Aires, Argentina.

Parkinson'S Disease
|March 16, 2011
PubMed
Summary
This summary is machine-generated.

Peripheral infections worsen neurodegeneration in Parkinson's disease (PD). This study reviews how inflammation impacts PD progression and suggests anti-inflammatory treatments may offer neuroprotection for patients.

Related Experiment Videos

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Peripheral inflammation can exacerbate central nervous system damage in neurodegenerative diseases.
  • Systemic inflammatory stimuli trigger sickness behavior and cytokine synthesis in the brain.
  • In Parkinson's disease (PD), inflammation is linked to microglia activation, potentially causing substantia nigra neuron loss.

Purpose of the Study:

  • To analyze the role of peripheral infections in the etiology and progression of Parkinson's disease.
  • To review evidence on how peripheral immune challenges affect PD symptoms and neurodegeneration.
  • To explore the potential neuroprotective effects of anti-inflammatory treatments in PD.

Main Methods:

  • Literature review of studies on peripheral inflammation and Parkinson's disease.
  • Analysis of animal models and human patient data.
  • Examination of the impact of systemic inflammation on microglia activation and neurodegeneration.

Main Results:

  • Peripheral inflammation transforms "primed" microglia into an "active" state, intensifying neurodegenerative processes.
  • Numerous studies demonstrate that systemic inflammation exacerbates neurodegeneration in PD patients and models.
  • Anti-inflammatory treatments have shown neuroprotective effects in PD patients.

Conclusions:

  • Peripheral infections can significantly exacerbate symptoms and progression in Parkinson's disease.
  • Immune challenges originating outside the central nervous system play a critical role in PD.
  • Targeting peripheral inflammation may be a viable therapeutic strategy for Parkinson's disease.